Loading...

Length 
138 pages

Date published 
March 2008

Additional info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.

Loading...

Country, Global license:
Contact Jack Valeri,
Global Report Sales
781-972-1355

Corporate subscriptions:
Contact David Cunningham,
Global Report Sales
781-972-5472

Questions?
Contact Rose LaRaia
Customer Service
781-972-5444

Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn EMail Page Printer Friendly Book Mark

MicroRNAs: Commercial Products on the Horizon: Survey Questions

Loading...

 

MicroRNAs: Commercial Products on the Horizon

Author: Ricki Lewis, PhD

Objective: To illuminate trends, current practices, and views about microRNA R&D and potential markets.

Participation: Individuals in life science R&D whose work involves microRNA R&D.

Questions:

  1. Please classify your organization.
  2. Under what functional role do your responsibilities fall?
  3. What is your title?
  4. What is your area of expertise?
  5. How long have you been conducting research on microRNAs?
  6. What is the nature of your work on microRNAs?
  7. Does your work on microRNAs focus on any of the following?
  8. If applicable, please indicate which areas your clinical research focuses on.
  9. If applicable, please indicate which areas your cancer research focuses on.
  10. Which system(s) do you work with?
  11. Which aspects of microRNA function do you investigate?
  12. Which microRNAs do you investigate?
  13. What tools do you use to obtain or characterize microRNAs?
  14. What bioinformatics tools do you use?
  15. What databases do you use?
  16. What tools do you use to inhibit microRNAs to identify targets?
  17. What companies' products do you use for microRNA isolation, purification, amplification, and/or sequencing?
  18. Do you use microRNA expression and target expression microarray products from any of these sources?
  19. Do you use bead-based microRNA assays from these sources?
  20. Do you work with any of the following companies that are conducting drug target screening based on microRNA?
  21. How many years do you estimate that the first microRNA-based product will be used in the clinic?
  22. In which clinical areas do you think microRNAs will be applied?
  23. Please rate the following challenges that researchers face in understanding microRNA function sufficiently to harness it in clinical or research applications.
  24. Please rate the following tools for their potential to improve analysis of microRNAs.